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Early-onset Fuchs’ endothelial corneal dystrophy (FECD) is a rare, and almost always 
familial disease with autosomal dominant inheritance (1). To date, mutations in only the 
COL8A2 (alpha 2 type VIII collagen) gene (MIM 120252; 1p34.2) have been reported to 
cause this disease (1, 2). So far, only one Australian family has been reported to develop the 
disease due to the p.Q455K mutation in COL8A2 (1). To determine whether mutations in this 
gene cause the disease in other similar cases in Australia, we screened the entire coding 
region of the COL8A2 gene for causative mutations in an affected Caucasian family. The 
study was conducted in accordance with the tenets of the Declaration of Helsinki and was 
approved by the Southern Adelaide Clinical Human Research Ethics Committee (Adelaide).   
Multiple members of the three-generation family (Fig. 1) were independently examined by 
six ophthalmologists at different times and institutions. Available clinical information is 
given in Table 1. Two (II.2 and III.2) of the family members were clinically diagnosed with 
advanced stage disease following their referral to ophthalmologists. Patients II.2 and III.2 
underwent unilateral corneal grafting at the ages of 49 and 48, respectively, to prevent vision 
loss. The histopathological findings confirmed a diagnosis of early-onset FECD (Table 1) (2). 
Patient II.2 also had keratoconus (since 15 years of age), blue dot congenital cataract and 
Map dot fingerprint corneal degeneration. Patient IV.2, the youngest member of the family, 
was clinically diagnosed with early-onset FECD at 21 years of age, but has not undergone 
any corneal transplantation as yet. She had visual acuities of 6/9 (right eye) and 6/12 (left 
eye). Clinical details were not available for individual III.4 but other family members 
reported that he was diagnosed with endothelial corneal dystrophy, keratoconus and Herpes 
Simplex Virus (HSV) keratitis. His son (IV.3) is also reported to have endothelial corneal 
dystrophy but has not been examined. It was also reported that patient I.1 had bilateral 
corneal transplants at the age of 62; therefore, he was inferred to have FECD. Neither 
individual I.1 nor IV.3 was available for this study. Overall, the family displayed an 
autosomal dominant mode of inheritance of the disease (Fig. 1). 
Four affected family members were recruited (through the Eye Clinic, Flinders Medical 
Centre, Adelaide) to participate in this study following written informed consent. Blood 
samples were collected and genomic DNA was extracted as previously described (3).  
The two coding exons and their flanking sequence incorporating the 5’UTR (untranslated 
region), splice sites and stop codon of the COL8A2 gene were amplified by polymerase chain 
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reaction (PCR) using gene-specific primers (Supplementary Table1) in each DNA sample. 
The PCR products were sequenced as previously described (3).  
We identified only one intronic SNP (rs274754; G/A) in individuals II.2 and IV.2, as reported 
in the dbSNP 135 database (http://www.ncbi.nlm.nih.gov/sites/entrez?db=snp). The minor 
allele frequency of the G allele of this SNP in the 1000Genomes Project 
(www.1000genomes.org) is 0.491. This SNP is highly unlikely to be causative as it is a 
common polymorphism and is present in individuals without early-onset FECD. 
Neither of the previously reported disease-causing mutations in COL8A2 (p.L450W and 
p.Q455K) (1, 2), were observed in this family and no novel mutations were identified. This is 
only the second study to investigate this gene in Australian cases with early-onset FECD. Our 
finding suggests that mutation in this gene does not contribute to the disease and as yet 
undetermined gene/s are likely to account for the disease in this Caucasian Australian family.  
Our results are supported by other studies that also reported absence of mutation in the 
COL8A2 gene in familial or sporadic early-onset FECD in French and Indian cases (4, 5). 
Given the heterogeneity of FECD, it is likely that mutations in genes other than COL8A2 lead 
to the early-onset disease (2). Two members (II.2 and III.4) of the studied family also have 
other corneal conditions (Table 1), suggesting that there may be genetic overlap between 
FECD and other diseases including keratoconus. Keratoconus has never been reportedly 
associated with familial or sporadic early-onset FECD in patients with COL8A2 mutations, 
which indicates a further distinction between the present family and those reported in 
previous studies.  
In summary, mutations in the COL8A2 gene do not contribute to all cases of early-onset 
FECD. We hypothesize that mutations in as yet undetermined gene/s are likely to account for 
the disease in some cases with early-onset disease. 
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Figure legends 
Figure 1. The pedigree of the Caucasian Australian family with familial early-onset FECD. 
Squares = males; circles = females; white shapes = unaffected; black shapes = clinically 
confirmed as affected by FECD; * = DNA available for genetic screening of COL8A2; Grey 
shape = Affected by Keratoconus only. 
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Table 1: Clinical and histopathological findings in individuals from the Caucasian Australian family with early-onset Fuchs’ endothelial corneal 
dystrophy (FECD). KC = Keratoconus; HSV = Herpes Simplex Virus; LE = left eye; RE = right eye; DM = Descemet’s membrane; EM = 
Electron microscopy. 
Individual Diagnosis History & Clinical Findings Corneal Histopathology 
I.1 FECD Penetrating keratoplasty in both eyes, presumed for 
FECD 
Not available 
II.2 KC 
FECD 
Both eyes: 
Central corneal thinning  
Fleischer rings 
Abnormal endothelium 
Corneal oedema 
Blue-dot congenital cataracts 
Map-dot fingerprint corneal degeneration 
Penetrating keratoplasty LE 1991, RE 2001 
LE: Attenuated endothelium, no 
posterior nodularity of DM, 
thickened 3 layered DM and 
stromal deposits of unknown 
significance on EM. 
RE: Reduced endothelial density, 
stromal oedema, subepithelial 
bullae. 
III.2 FECD Corneal oedema RE 
Abnormal endothelium both eyes 
Penetrating keratoplasty RE 2002 
RE: Attenuated endothelium, 
thickened 4 layered DM on EM 
III.4 FECD 
KC 
HSV keratitis 
Not examined Not available 
IV.2 FECD Both eyes: 
Corneal guttata 
Corneal oedema 
Reduced endothelial density  
Not available 
IV.3 FECD Not examined Not available 
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Supplementary Table 1. Primers and PCR conditions used for mutation screening of the COL8A2 gene. Primer sequences, primer annealing 
temperature in degrees centigrade, and the use of Q solution are indicated. Primers were designed using the Primer3 software 
(http://frodo.wi.mit.edu/primer3/). 
Amplimers Forward Primer 5’>3’ Reverse Primer 5’>3’ Annealing Temp (C) Q Solution Added? 
1 ATTCGGAATTGCTTCTCAGC GCCCTCTGGGGTATTAGGAA 57 No 
2.1 TCCTCTCCCGTGTACCTCAT CCTGGTTTTCCAGGGATAGTA 57 No 
2.2 CAGGAATACGAGGGGACCA AGTCCTGGCATCCCATAGC 56 Yes 
2.3 GGAGACAAGGGTGAGTCTGG AGGAAGTCCCCTCTCACCTG 57 Yes 
2.4 TGACCAGGGGCCTAGTGG CGATGCCAGTCTCATCGAA 57 Yes 
2.5 CTGGCTCCCCTGGAATCA CCGGCACGTTGTTCTTGTA 57 Yes 
2.6 CGTGAAATTTGACCGGACTC CATGCAGGGAGAAAGCAAGT 57 No 
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